2019
Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic
KOCIAN, Petr, Ivana SVOBODOVÁ, Denisa KREJČÍ, Milan BLAHA, Robert GURLICH et. al.Základní údaje
Originální název
Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic
Autoři
KOCIAN, Petr (203 Česká republika), Ivana SVOBODOVÁ (203 Česká republika, domácí), Denisa KREJČÍ (203 Česká republika, domácí), Milan BLAHA (203 Česká republika, domácí), Robert GURLICH (203 Česká republika), Ladislav DUŠEK (203 Česká republika, domácí), Jiri HOCH (203 Česká republika) a Adam WHITLEY (203 Česká republika, garant)
Vydání
Cancer epidemiology, Oxford, Elsevier, 2019, 1877-7821
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.179
Kód RIV
RIV/00216224:14110/19:00112407
Organizační jednotka
Lékařská fakulta
UT WoS
000504659600021
Klíčová slova anglicky
Colorectal cancer; Age; Survival; Population study; Epidemiology
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 15. 1. 2020 14:40, Mgr. Tereza Miškechová
Anotace
V originále
Introduction: The incidence of colorectal cancer in young patients is increasing. The goal of this study was to investigate whether clinicopathological features and survival differed between young, middle-aged and elderly patients. Methods: The Czech National Cancer Registry was searched to identify all cases of colorectal cancer between 1982 and 2014. Three subgroups of patients were created: young patients, defined as being between 18 and 40 years of age, middle-aged patients, defined as being between 41 and 74 years of age, and elderly patients, defined as being over the age of 75 years. Results: A total of 192,241 patients diagnosed with colorectal cancer between the years 1982 and 2014 were included in the study. Out of these, 3,287 patients (1.7%) were between 18 and 40 years of age, 134,139 patients (69.8%) were between 41 and 74 years of age and 54,815 patients (28.5%) were 75 years of age or older. The young patients had a higher incidence of mucinous adenocarcinoma and signet ring cell carcinoma, more advanced disease and more rectal tumours than elderly patients. Nonetheless, young patients received treatment more frequently and had better cancer-specific survival than the older patients. Conclusion: The better prognosis in young patients is presumably due to their better physiological reserve and lower incidence of comorbidities. Efforts should be made in younger patients to diagnose early and treat aggressively.